Anti-retinal IgG antibodies in patients with early and advanced type 2 macular telangiectasia. McLenachan S, Balaratnasingam C, Heath Jeffery RC, Chen SC, et al. Exp Eye Res 2022 Mar 7:109024. doi: 10.1016/j.exer.2022.109024.

Read + Share

Amedeo Smart

Independent Medical Education

McLenachan S, Balaratnasingam C, Heath Jeffery RC, Chen SC, et al. Anti-retinal IgG antibodies in patients with early and advanced type 2 macular telangiectasia. Exp Eye Res 2022 Mar 7:109024. doi: 10.1016/j.exer.2022.109024.
PMID: 35271830